Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
EDO 1,2-ethanediol
F2S 11-[(2r)-butan-2-yl]-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6h-pyrimido[4,5-B][1,4]benzodiazepin-6-one
FND 11-[(2s)-butan-2-yl]-2-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6h-pyrimido[4,5-B][1,4]benzodiazepin-6-one
NO3 Nitrate ion
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6CJ1   PDBj   RCSB PDB   PDBe
Header : TRANSCRIPTION/INHIBITOR
Title : Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG071
Release Data : 2018-08-29
Compound :
mol_id molecule chains synonym
1 Bromodomain-containing protein 4 A Protein HUNK1
fragment: residues 44-166
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: BRD4, HUNK1
Authors : Xu, X., Blacklow, S.C.
Keywords : Kinase, Inhibitor, BRD4, TRANSCRIPTION, TRANSCRIPTION-INHIBITOR complex
Exp. method : X-RAY DIFFRACTION ( 1.530 Å )
Citation :

Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.

Wang, J.,Erazo, T.,Ferguson, F.M.  et al.
(2018)  ACS Chem. Biol.  13 : 2438 - 2448

PubMed: 30102854
DOI: 10.1021/acschembio.7b00638

Chain : A
UniProt : O60885 (BRD4_HUMAN)
Reaction : -